Cargando…
PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
INTRODUCTION: Hyperosmolar crisis, which includes diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), is a severe and acute complication of diabetes. The estimated mortality rates of DKA and HHS are 6.8% and 10%, respectively (Benoit, Zhang, Geiss, Gregg, & Albright, 2018) (P...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624590/ http://dx.doi.org/10.1210/jendso/bvac150.784 |
_version_ | 1784822268105326592 |
---|---|
author | Silgado, Maria Laura Ricardo Apoorva, Tangri Tarhoni, Imad Bagar, Darin Hasan, Muqdad Kubbar, Alaa Karnik, Suruchi Iwuala, Sandra Trusty, Rhonda-Kaye Aroyewun, Opeyemi Rashmi, Prama Bhusal, Sandhya Rippe, Edward Hamid Hashmi, Syed Salman Tahir, Muhammad Mahalli, Joseph Gorbonos, Allen Kamat, Arnav Bahtiyar, Gul Rodriguez, Giovanna |
author_facet | Silgado, Maria Laura Ricardo Apoorva, Tangri Tarhoni, Imad Bagar, Darin Hasan, Muqdad Kubbar, Alaa Karnik, Suruchi Iwuala, Sandra Trusty, Rhonda-Kaye Aroyewun, Opeyemi Rashmi, Prama Bhusal, Sandhya Rippe, Edward Hamid Hashmi, Syed Salman Tahir, Muhammad Mahalli, Joseph Gorbonos, Allen Kamat, Arnav Bahtiyar, Gul Rodriguez, Giovanna |
author_sort | Silgado, Maria Laura Ricardo |
collection | PubMed |
description | INTRODUCTION: Hyperosmolar crisis, which includes diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), is a severe and acute complication of diabetes. The estimated mortality rates of DKA and HHS are 6.8% and 10%, respectively (Benoit, Zhang, Geiss, Gregg, & Albright, 2018) (Pasquel & Umpierrez, 2014). There is limited evidence regarding the clinical characteristics, hospital complications, and mortality rate of patients with combined DKA and HHS. Therefore, we aim to compare hospital outcomes between patients with DKA, HHS, and combined DKA and HHS in a community hospital in Brooklyn, NY. METHODOLOGY: We performed a retrospective analysis from the patients admitted for DKA and/or HHS at Health+Hospitals / Woodhull from 2019 to 2021. Descriptive statistics were used to determine the frequency of patients in each hyperglycemic group and their clinical characteristics. Using one-way ANOVA and Chi-square test, we compared the demographics and clinical outcomes between subgroups. Multivariate regression analysis and log-rank test were used to assess the influence of multiple variables on hospital mortality and the difference in survival between groups, respectively. RESULTS: We studied 263 patients admitted for a hyperglycemic crisis, DKA (58%), HHS (14%), and DKA+HHS (28%). Baseline characteristics of the population include male (60%), African American (42%), Hispanic (32%), and mean BMI of 28±8 kg/m(2). No difference was found in mean admission HbA1c (DKA 12±2.6%, HHS 12.7±3%, DKA+HHS 12.7±2.5%, p: 0.08). Patients with HHS were older (mean age 56±15) compared with DKA (47±17) and DKA+HHS (49±18). Patients with DKA+HHS had higher mean admission blood sugar (893±330 mg/dL), compared with DKA (497±206 mg/dL) and HHS (808±346 mg/dL) (p <0.001). There was no difference in the frequency of hypokalemia, K+ <3.5 mEq/L (DKA 26.9%, HHS 6.3%, DKA+HHS 12.6%, p: 0.8); hypoglycemia (DKA 12%, HHS 4.6%, DKA+HHS 7%, p: 0.2); or cerebral edema (DKA 0.8%, HHS 0.4%, DKA+HHS 1.5%, p: 0.1) between the groups. However, the frequency of acute kidney injury (AKI) was higher in DKA (24.7%) than in HHS (7%) or DKA+HHS (16.7%) (p: 0.034). There was no difference in the mean days of hospital stay (DKA 8.5±28, HHS 7±8, DKA+HHS 8±10, p: 0.9) and in-hospital mortality (DKA 3.4%, HHS 3.5%, DKA+HHS 4%, p: 0.069) among the groups. In all subtypes of hyperglycemic crisis, the mortality rate was significantly higher with older age, presence of AKI, cerebral edema, and vasopressor requirement. CONCLUSIONS: There was no significant difference in mortality, length of admission, prevalence of hypoglycemia, hypokalemia, and cerebral edema between the three groups. The prevalence of AKI was significantly higher in DKA compared with HHS and DKA+HHS. Older age, presence of AKI, cerebral edema, and vasopressor requirement were mortality predictors among hyperglycemic crisis. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m. |
format | Online Article Text |
id | pubmed-9624590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96245902022-11-14 PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Silgado, Maria Laura Ricardo Apoorva, Tangri Tarhoni, Imad Bagar, Darin Hasan, Muqdad Kubbar, Alaa Karnik, Suruchi Iwuala, Sandra Trusty, Rhonda-Kaye Aroyewun, Opeyemi Rashmi, Prama Bhusal, Sandhya Rippe, Edward Hamid Hashmi, Syed Salman Tahir, Muhammad Mahalli, Joseph Gorbonos, Allen Kamat, Arnav Bahtiyar, Gul Rodriguez, Giovanna J Endocr Soc Diabetes & Glucose Metabolism INTRODUCTION: Hyperosmolar crisis, which includes diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS), is a severe and acute complication of diabetes. The estimated mortality rates of DKA and HHS are 6.8% and 10%, respectively (Benoit, Zhang, Geiss, Gregg, & Albright, 2018) (Pasquel & Umpierrez, 2014). There is limited evidence regarding the clinical characteristics, hospital complications, and mortality rate of patients with combined DKA and HHS. Therefore, we aim to compare hospital outcomes between patients with DKA, HHS, and combined DKA and HHS in a community hospital in Brooklyn, NY. METHODOLOGY: We performed a retrospective analysis from the patients admitted for DKA and/or HHS at Health+Hospitals / Woodhull from 2019 to 2021. Descriptive statistics were used to determine the frequency of patients in each hyperglycemic group and their clinical characteristics. Using one-way ANOVA and Chi-square test, we compared the demographics and clinical outcomes between subgroups. Multivariate regression analysis and log-rank test were used to assess the influence of multiple variables on hospital mortality and the difference in survival between groups, respectively. RESULTS: We studied 263 patients admitted for a hyperglycemic crisis, DKA (58%), HHS (14%), and DKA+HHS (28%). Baseline characteristics of the population include male (60%), African American (42%), Hispanic (32%), and mean BMI of 28±8 kg/m(2). No difference was found in mean admission HbA1c (DKA 12±2.6%, HHS 12.7±3%, DKA+HHS 12.7±2.5%, p: 0.08). Patients with HHS were older (mean age 56±15) compared with DKA (47±17) and DKA+HHS (49±18). Patients with DKA+HHS had higher mean admission blood sugar (893±330 mg/dL), compared with DKA (497±206 mg/dL) and HHS (808±346 mg/dL) (p <0.001). There was no difference in the frequency of hypokalemia, K+ <3.5 mEq/L (DKA 26.9%, HHS 6.3%, DKA+HHS 12.6%, p: 0.8); hypoglycemia (DKA 12%, HHS 4.6%, DKA+HHS 7%, p: 0.2); or cerebral edema (DKA 0.8%, HHS 0.4%, DKA+HHS 1.5%, p: 0.1) between the groups. However, the frequency of acute kidney injury (AKI) was higher in DKA (24.7%) than in HHS (7%) or DKA+HHS (16.7%) (p: 0.034). There was no difference in the mean days of hospital stay (DKA 8.5±28, HHS 7±8, DKA+HHS 8±10, p: 0.9) and in-hospital mortality (DKA 3.4%, HHS 3.5%, DKA+HHS 4%, p: 0.069) among the groups. In all subtypes of hyperglycemic crisis, the mortality rate was significantly higher with older age, presence of AKI, cerebral edema, and vasopressor requirement. CONCLUSIONS: There was no significant difference in mortality, length of admission, prevalence of hypoglycemia, hypokalemia, and cerebral edema between the three groups. The prevalence of AKI was significantly higher in DKA compared with HHS and DKA+HHS. Older age, presence of AKI, cerebral edema, and vasopressor requirement were mortality predictors among hyperglycemic crisis. Presentation: Sunday, June 12, 2022 12:30 p.m. - 2:30 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9624590/ http://dx.doi.org/10.1210/jendso/bvac150.784 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Diabetes & Glucose Metabolism Silgado, Maria Laura Ricardo Apoorva, Tangri Tarhoni, Imad Bagar, Darin Hasan, Muqdad Kubbar, Alaa Karnik, Suruchi Iwuala, Sandra Trusty, Rhonda-Kaye Aroyewun, Opeyemi Rashmi, Prama Bhusal, Sandhya Rippe, Edward Hamid Hashmi, Syed Salman Tahir, Muhammad Mahalli, Joseph Gorbonos, Allen Kamat, Arnav Bahtiyar, Gul Rodriguez, Giovanna PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State |
title | PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State |
title_full | PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State |
title_fullStr | PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State |
title_full_unstemmed | PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State |
title_short | PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State |
title_sort | psun194 inpatient outcomes of combined diabetic ketoacidosis and hyperosmolar hyperglycemic state |
topic | Diabetes & Glucose Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624590/ http://dx.doi.org/10.1210/jendso/bvac150.784 |
work_keys_str_mv | AT silgadomarialauraricardo psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT apoorvatangri psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT tarhoniimad psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT bagardarin psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT hasanmuqdad psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT kubbaralaa psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT karniksuruchi psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT iwualasandra psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT trustyrhondakaye psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT aroyewunopeyemi psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT rashmiprama psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT bhusalsandhya psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT rippeedward psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT hamidhashmisyedsalman psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT tahirmuhammad psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT mahallijoseph psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT gorbonosallen psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT kamatarnav psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT bahtiyargul psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate AT rodriguezgiovanna psun194inpatientoutcomesofcombineddiabeticketoacidosisandhyperosmolarhyperglycemicstate |